Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

Hepatology

Volumn 63, Issue 2, 2016, Pages 604-619

  López Luque, Judit ^a   Caballero Díaz, Daniel ^a   Martinez Palacián, Adoración ^b   Roncero, César ^b   Moreno Càceres, Joaquim ^a   García Bravo, María ^c,d,e   Grueso, Esther ^c,d,k   Fernández, Almudena ^d,f   Crosas Molist, Eva ^a   García Álvaro, María ^b   Addante, Annalisa ^b   Bertran, Esther ^a   Valverde, Angela M ^g,h   González Rodríguez, Águeda ^g,h   Herrera, Blanca ^b   Montoliu, Lluis ^d,f   Serrano, Teresa ⁱ   Segovia, Jose Carlos ^c,d,e   Fernández, Margarita ^b   Ramos, Emilio ⁱ   Sánchez, Aránzazu ^b   Fabregat, Isabel ^a,j   more..

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CIEMAT   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^e 28400 Madrid   (Spain)

^f CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^g INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^j UNIVERSITY OF BARCELONA   (Spain)

^k PAUL EHRLICH INSTITUT   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BIM PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DIETHYLNITROSAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN BCL XL; PROTEIN BMF; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOSTASIS; FEMALE; GENE AMPLIFICATION; HEPATITIS; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; METABOLIC REGULATION; MOUSE; MOUSE MODEL; MOUSE MUTANT; NONHUMAN; PARTIAL HEPATECTOMY; PRECANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; CARCINOGENESIS; CATALYSIS; HUMAN; LIVER NEOPLASMS; MALE; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; CATALYSIS; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84956841230     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28134     Document Type: Article

References (39)

1. Berasain C, Avila MA. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol 2014;49:9-23.
2. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2-13.
3. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26(Suppl. 1):203-212.
4. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol 2012;57:692-694.
5. Carmona-Cuenca I, Herrera B, Ventura J-J, Roncero C, Fernández M, Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J Cell Physiol 2006;207:322-330.
6. Fabregat I, Herrera B, Fernández M, Alvarez AM, Sánchez A, Roncero C, et al. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway. Hepatology 2000;32:528-535.
7. Caja L, Sancho P, Bertran E, Fabregat I. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells. J Hepatol 2011;55:351-358.
8. Skarpen E, Oksvold MP, Grøsvik H, Widnes C, Huitfeldt HS. Altered regulation of EGF receptor signaling following a partial hepatectomy. J Cell Physiol 2005;202:707-716.
9. Livneh E, Prywes R, Kashles O, Reiss N, Sasson I, Mory Y, et al. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J Biol Chem 1986;261:12490-12497.
10. Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol 1991;11:1454-1463.
11. Murillas R, Larcher F, Conti CJ, Santos M, Ullrich A, Jorcano JL. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J 1995;14:5216-5223.
12. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 2005;33:e36.
13. Giraldo P, Montoliu L. Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 2001;10:83-103.
14. Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, et al. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 2003;52:2239-2248.
15. Higgins GM, Anderson R. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
16. Sancho P, Bertran E, Caja L, Carmona-Cuenca I, Murillo MM, Fabregat I. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochim Biophys Acta 2009;1793:253-263.
17. Caja L, Ortiz C, Bertran E, Murillo MM, Miró-Obradors MJ, Palacios E, et al. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. Cell Signal 2007;19:683-694.
18. Murillo MM, del Castillo G, Sánchez A, Fernández M, Fabregat I. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 2005;24:4580-4587.
19. Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005;280:2562-2568.
20. Arandjelovic S, Freed TA, Gonias SL. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta. Biochemistry (Mosc) 2003;42:6121-6127.
21. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernández M, et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 2008;49:965-976.
22. Crosas-Molist E, Bertran E, Sancho P, López-Luque J, Fernando J, Sánchez A, et al. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression. Free Radic Biol Med 2014;69:338-347.
23. Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 2001;33:569-576.
24. Huang P, Xu X, Wang L, Zhu B, Wang X, Xia J. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment. J Cell Mol Med 2014;18:218-230.
25. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 2007;104:17081-17086.
26. Oe S, Lemmer ER, Conner EA, Factor VM, Levéen P, Larsson J, et al. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 2004;40:1098-1105.
27. Romero-Gallo J, Sozmen EG, Chytil A, Russell WE, Whitehead R, Parks WT, et al. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 2005;24:3028-3041.
28. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004;40:1322-1332.
29. Obayashi Y, Campbell JS, Fausto N, Yeung RS. Impaired lipid accumulation in the liver of Tsc2-heterozygous mice during liver regeneration. Biochem Biophys Res Commun 2013;437:146-150.
30. Rudnick DA, Davidson NO. Functional relationships between lipid metabolism and liver regeneration. Int J Hepatol 2012;2012:549241.
31. Paranjpe S, Bowen WC, Tseng GC, Luo J-H, Orr A, Michalopoulos GK. RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am J Pathol 2010;176:2669-2681.
32. 2/M progression during liver regeneration in mice. PloS One 2010;5(9).
33. Gao L, Utsumi T, Tashiro K, Liu B, Zhang D, Swenson ES, et al. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice. Hepatology 2013;57:1992-2003.
34. Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005;41:307-314.
35. Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY, et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 2014;59:1577-1590.
36. Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009;234:713-725.
37. Lanaya H, Natarajan A, Komposch K, Li L, Amberg N, Chen L, et al. EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat Cell Biol 2014;16:972-981.
38. Ziraldo C, Vodovotz Y, Namas RA, Almahmoud K, Tapias V, Mi Q, et al. Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies. PloS One 2013;8:e79804.
39. Han K-Q, He X-Q, Ma M-Y, Guo X-D, Zhang X-M, Chen J, et al. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. World J Gastroenterol 2015;21:4864-4874.